Christy J. Oliger

Insider Reports History

Entity
Individual
Location
85 Wells Avenue, Suite 210, Newton, MA
Signature
/s/ Joseph R. Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christy J. Oliger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vera Therapeutics, Inc. Director Class A Common Stock 2.99K $129K $43.03 Jun 7, 2024 Direct
Karyopharm Therapeutics Inc. Director Nonstatutory Stock Option (right to buy) 69K May 29, 2024 Direct
Replimune Group, Inc. Director Stock Option (right to buy) 32K Apr 1, 2024 Direct
Vera Therapeutics, Inc. Director Stock Option (right to buy) 25K Jun 7, 2024 Direct
RayzeBio, Inc. Director Employee Stock Option (Right to Buy) 0 Feb 26, 2024 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Sep 26, 2023 Direct
Sierra Oncology, Inc. Director Stock Option (right to buy) 0 Jul 1, 2022 Direct

Insider Reports Filed by Christy J. Oliger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERA Vera Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
VERA Vera Therapeutics, Inc. Jun 7, 2024 0 $0 3 Jun 11, 2024 Director
KPTI Karyopharm Therapeutics Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
REPL Replimune Group, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 1 $0 4 Feb 27, 2024 Director
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 8 $0 4 Sep 26, 2023 Director
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Director
RETA REATA PHARMACEUTICALS INC Jun 7, 2023 2 $157K 4 Jun 9, 2023 Director
KPTI Karyopharm Therapeutics Inc. May 24, 2023 1 $0 4 May 25, 2023 Director
REPL Replimune Group, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
SRRA Sierra Oncology, Inc. Jul 1, 2022 1 $0 4 Jul 1, 2022 Director
RETA REATA PHARMACEUTICALS INC Jun 8, 2022 2 $135K 4 Jun 9, 2022 Director
KPTI Karyopharm Therapeutics Inc. May 19, 2022 1 $0 4 May 20, 2022 Director
REPL Replimune Group, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
REPL Replimune Group, Inc. Dec 1, 2021 1 $0 4 Dec 3, 2021 Director
REPL Replimune Group, Inc. Dec 1, 2021 0 $0 3 Dec 3, 2021 Director
RETA REATA PHARMACEUTICALS INC Jun 10, 2021 2 $15K 4 Jun 14, 2021 Director
SRRA Sierra Oncology, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
SRRA Sierra Oncology, Inc. Jun 2, 2021 0 $0 3 Jun 4, 2021 Director
KPTI Karyopharm Therapeutics Inc. May 21, 2021 1 $0 4 May 21, 2021 Director